SEC Form 4 · accession 0001209191-15-032975
MABVAX THERAPEUTICS HOLDINGS, INC. · MBVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey V. Ravetch
Director
Period of report
Apr 4, 2015
Accepted (ET)
Apr 7, 2015 · 8:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001109196
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 4, 2015 | A | 131,500 | $0.00 | A | 131,500 | D |
Table II — derivative securities
No Table II lines on this filing.